These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21335078)

  • 21. Hydroxypropyl-beta-cyclodextrin inhibits spray-drying-induced inactivation of beta-galactosidase.
    Branchu S; Forbes RT; York P; Petrén S; Nyqvist H; Camber O
    J Pharm Sci; 1999 Sep; 88(9):905-11. PubMed ID: 10479352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spray-drying of proteins: effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G.
    Maury M; Murphy K; Kumar S; Mauerer A; Lee G
    Eur J Pharm Biopharm; 2005 Feb; 59(2):251-61. PubMed ID: 15661497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovative approach to produce submicron drug particles by vibrational atomization spray drying: influence of the type of solvent and surfactant.
    Durli TL; Dimer FA; Fontana MC; Pohlmann AR; Beck RC; Guterres SS
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1011-20. PubMed ID: 23672183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid.
    Hansen T; Holm P; Schultz K
    Int J Pharm; 2004 Dec; 287(1-2):55-66. PubMed ID: 15541912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality by design - Spray drying of insulin intended for inhalation.
    Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
    Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spray drying from organic solvents to prepare nanoporous/nanoparticulate microparticles of protein: excipient composites designed for oral inhalation.
    Ní Ógáin O; Tajber L; Corrigan OI; Healy AM
    J Pharm Pharmacol; 2012 Sep; 64(9):1275-90. PubMed ID: 22881440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality by design approach in the optimization of the spray-drying process.
    Baldinger A; Clerdent L; Rantanen J; Yang M; Grohganz H
    Pharm Dev Technol; 2012; 17(4):389-97. PubMed ID: 21275777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
    Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained delivery by leucine-modified chitosan spray-dried respirable powders.
    Learoyd TP; Burrows JL; French E; Seville PC
    Int J Pharm; 2009 May; 372(1-2):97-104. PubMed ID: 19429272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.
    Focaroli S; Mah PT; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
    Int J Pharm; 2019 May; 562():228-240. PubMed ID: 30849470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of a spray drying process to prepare dry powder microparticles containing plasmid nanocomplex.
    Mohajel N; Najafabadi AR; Azadmanesh K; Vatanara A; Moazeni E; Rahimi A; Gilani K
    Int J Pharm; 2012 Feb; 423(2):577-85. PubMed ID: 22101289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
    Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
    Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of some water-miscible organic solvents for spray-drying enzymes and carbohydrates.
    Sass A; Lee G
    Drug Dev Ind Pharm; 2014 Jun; 40(6):749-57. PubMed ID: 23596974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How surface composition of high milk proteins powders is influenced by spray-drying temperature.
    Gaiani C; Morand M; Sanchez C; Tehrany EA; Jacquot M; Schuck P; Jeantet R; Scher J
    Colloids Surf B Biointerfaces; 2010 Jan; 75(1):377-84. PubMed ID: 19811896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of melibiose and trehalose as stabilising excipients for spray-dried β-galactosidase formulations.
    Lipiäinen T; Räikkönen H; Kolu AM; Peltoniemi M; Juppo A
    Int J Pharm; 2018 May; 543(1-2):21-28. PubMed ID: 29567196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single step bottom-up process to generate solid phospholipid nano-particles.
    Brinkmann-Trettenes U; Barnert S; Bauer-Brandl A
    Pharm Dev Technol; 2014 May; 19(3):326-32. PubMed ID: 23528006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ coating--an approach for particle modification and encapsulation of proteins during spray-drying.
    Elversson J; Millqvist-Fureby A
    Int J Pharm; 2006 Oct; 323(1-2):52-63. PubMed ID: 16887302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.